HETLIOZ
Pronunciation: tas-i-MEL-tee-on


What it isMT1 and MT2 melatonin receptor agonist; non-24-hour sleep-wake disorder in blind patients.
Why this oneIt entrains the circadian clock in people with no light perception, which nothing else does.
What limits itEntrainment takes weeks to months. CYP1A2 and CYP3A4 dependent; avoid with fluvoxamine.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Non-24-hour sleep-wake disorder | Adults (capsules) | 20 mg QHS | 20 mg QHS | 20 mg QHS |
| Nighttime sleep disturbances in Smith-Magenis syndrome | ≥16 yr (capsules) | 20 mg QHS | 20 mg QHS | 20 mg QHS |
| Nighttime sleep disturbances in Smith-Magenis syndrome, ≤28 kg | Pediatric 3-15 yr (oral suspension) | 0.7 mg/kg QHS | 0.7 mg/kg QHS | 0.7 mg/kg QHS |
| Nighttime sleep disturbances in Smith-Magenis syndrome, >28 kg | Pediatric 3-15 yr (oral suspension) | 20 mg QHS | 20 mg QHS | 20 mg QHS |
Renal Undefined
Hepatic Severe: not studied, not recommended
Available strengths
Pregnancy Insufficient human data; no embryofetal toxicity in rats at tested exposures
Lactation No human or animal milk data
| Strength | #/mo | generic $ | CostPlus | |
|---|---|---|---|---|
| 20 mg | cap | 30 qd | $6,847.44/mo | offered |
| 4 mg/mL | susp | per unit | not offered |
Generic entry2022
NO BOXED WARNINGS
Principal riskEntrainment takes weeks to months
Legacy pregnancy categoryC
Defining liabilitySomnolence, headache and hepatic enzyme elevations; acute toxicity is generally limited.
Open Tasimelteon in the interactive console ↗
